Acumen Research and Consulting estimates that the global eubiotics market is anticipated to reach market size of around US$ 7,000 Mn by 2027 and is expected to grow at a CAGR of around 5% in terms of revenue during the forecast period 2020 – 2027.
Eubiotics are feed additives for animals which improve feed's nutritional value and improve animal health. Naturally, eubiotics help and protect the health of the animal stomach. Organic plant extracts and carboxylic acids are ingredients used in eubiotics.
Growing awareness regarding benefits of agricultural products and supportive policy policies to increase feed quality is expected to fuel the growth of the eubiotic industry. Such materials are used in the feeding of diets of beef and dairy calves, chickens, ruminants and aquaculture industries. Eubiotic products help the strengthening of the immune system and the fighting capacity of bacterial or viral infections. Increased meat consumption due to high meat productivity and convenient exposure to meat products that can increase food demand, would drive the market. Product specifications, increased disposable income and changing eating habit has led the global meat industry to over US$ 40 billion in 2018. Global meat demand is projected to hit up to 323 million tonnes, with 450 million tons predicted to cross by 2030. Throughout the expected span of time, the rise in disposable income along with solid growth in the processed food and drink industry would boost the demand on the eubiotic market. Manufacturers are investing in R&D to develop tailored products, brand awareness, and rise the market share of eubiotics. The industry leaders have created new growth prospects for reasons such as advancements in molecular biology and gene sequencing. Therefore, businesses collaborate together or cooperate in the production of technologies and product releases, and form agreements or distributor agreements. However, in addition to supply chain problems and reduced demand for meat goods COVID-19 outbreaks have affected the industry. Strict regulatory guidelines on the prohibition of antibiotics growth promoter (AGP) by the FDA and the EU Commission as a result of the bioaccumulation of antibiotics and meat products in the animal gastrointestinal tract, contribute to growing demands for natural growth promoters. The future substitutes for AGPs include products such as essential oils, organic acids, prebiotics and probiotics, which offer added benefits to the development of the eubiotics industry.
The US accounts for more than half of the demand in eubiotics in North America. The Food and Drug Administration's (FDA) ban on antibiotics in the United States in 2017 and ongoing research product advancement by local and global players are main factors driving demand growth. Pork, poultry and veal are the region's most common meat consumption. However, national governing bodies follow alternate sustainable strategies to produce high-quality, effective and safe feed additives. The US is a well-known market with high appetite for organic beef, which has driven producers to use natural ingredients in animal feed. The demand for eubiotics in animal feed in the country is also expected to increase. Europe is the largest eubiotic market of which the leading countries are Germany, France and UK. Prohibition of the use of antibiotics, enhanced environmental protection issues exacerbate business gains relative to other countries. America also has an immense growth opportunity in the eubiotic sector and is the fastest developing nation. Furthermore, rising fears about animal welfare are pushing the development of eubiotics in North America, as is the ban on the use of antibiotics in animal feed. Another region of the forthcoming eubiotics sector is Asia-Pacific. The demand is being driven by fast financial growth, increasing visibility, increased consumption of meat and dairy products. This gives eubiotic producers a huge opportunity to have superior feed consistency. Lack of knowledge and costs is still a restraining factor for the eubiotic market.
Major players included in this report are DSM, Alltech, BASF, Dupont, Cargill, Novozymes, Friesland Campina, Chr. Hansen, Lesaffre Group, Kemin Industries, Lallemand, Inc., Calpis, Friesland Campina, Novus International, and others. Throughout Asia-Pacific and in North American, the eubiotics market is concentrated and broken up into small regional players. Leading corporations concentrate on the purchase of feed mills, and independent farmers grow the sector both domestically and abroad. Many of the players expanded their global footprint in international markets by mergers with the local manufacturers.
The global eubiotics market is segmented as below:
Eubiotics Market By Type
Eubiotics Market By Livestock
Eubiotics Market By Function
Nutrition & Gut Health
Eubiotics Market By Dosage Form
Eubiotics Market By Geography
Middle East & Africa
The market value of eubiotics is anticipated to be around US$ 7,000 Mn in 2027
The market is anticipated to grow around 5% CAGR amid the forecast period.2020-2027
Europe held maximum share in 2019
Asia Pacific is projected to grow at a fast pace during forecast period from 2020-2027.
Emerging livestock diseases is expected to drive the growth of the eubiotics market.
Lack of systematic evaluation is a major factor expected to restraint the growth of the market
Major players included in this report are DSM, Alltech, BASF, Dupont, Cargill, Novozymes, Friesland Campina, Chr. Hansen, Lesaffre Group, Kemin Industries, Lallemand, Inc., Calpis, Friesland Campina, Novus International, and others.